Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1 domain family member 14 (TBC1D14) is a cytoplasmic protein characterized by a C-terminal TBC (Tre2-Bub2-Cdc16) domain typical for Rab GTPase-activating proteins (RabGAPs), although TBC1D14 does not exhibit classical RabGAP enzymatic activity. Its primary biological role is as a negative regulator of autophagy: TBC1D14 controls the delivery of membranes from RAB11-positive recycling endosomes to forming autophagosomes. It functions by interacting with the TRAPP complex—specifically with the TRAPPIII-like complex through the TRAPPC8 subunit—and modulating trafficking of ATG9, which is essential for autophagosome formation. Overexpression of TBC1D14 perturbs autophagy initiation and secretory trafficking. While it binds RAB11 and has features of a Rab effector, it does not act as a GAP for RAB11. TBC1D14 is localized to the Golgi, autophagosome, and recycling endosome. Currently, TBC1D14 is not categorized as a classical therapeutic target such as a receptor, enzyme, transporter, or ion channel[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 14 (TBC1D14).